Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient

Our rechallenge of cobimetinib in an Erdheim‐Chester Disease (ECD) patient for the rare adverse effect, “dropped head syndrome,” with a previously unexplored cobimetinib regimen was successful. Similar to other experiences with targeted agents in ECD, dosing of cobimetinib may vary to mitigate toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Amber C., Diamond, Eli L., Orozco, Jennifer S., Morse, Hannah R., Ouyang, Linda L., Schöder, Heiko, Rampal, Raajit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787838/
https://www.ncbi.nlm.nih.gov/pubmed/31624624
http://dx.doi.org/10.1002/ccr3.2297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787838/
https://www.ncbi.nlm.nih.gov/pubmed/31624624
http://dx.doi.org/10.1002/ccr3.2297

Ejemplares similares